Biotech and life sciences occupiers in Minneapolis typically cluster in North Loop, plan ~320 sqft per seat at high-end fit-out ($150–215/sqft), and pay around 32 USD/sqft ($32 USD) on Class A.
Biotech and life sciences occupiers in Minneapolis typically cluster in North Loop, plan ~320 sqft per seat at high-end fit-out">fit-out ($150–215/sqft), and pay around 32 USD/sqft ($32 USD) on Class A.
Biotech and life sciences occupiers in Minneapolis typically anchor in North Loop. Tech, creative agencies, advertising, food and beverage HQs.
Class A rent in Minneapolis runs 32 USD/sqft ($32 USD) on a 10-year lease with 16 months free. Prime submarkets sit at or modestly above the city index.
Typical biotech and life sciences fit-out targets high-end specification at $150–215/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 320 sqft per seat blended (workstation + circulation + amenity). A 100-headcount biotech office in Minneapolis typically targets 32,000 sqft of leasable area.
Cluster effects are decisive: PhD-grade talent concentrates near academic-medical anchors and translational research institutes. Deep Fortune 500 corporate, healthcare, retail, and agribusiness talent. Strong feed from the University of Minnesota and the broader UMN system. Healthcare talent base supports Mayo Clinic and UnitedHealth Group.
Headline corporate tax: 30.6%. Modified-gross structures with opex pass-throughs. 10-year terms standard for trophy. Free rent of 14-18 months and TI of $80-$120/sqft typical on a 10-year deal.
| city | Minneapolis |
|---|---|
| industry | Biotech and life sciences |
| naics | 541714, 541715, 325412 |
| preferredSubmarket | North Loop |
| preferredFitoutSpec | High-end |
| fitoutBand | $150–215/sqft |
| sqftPerSeat | 320 |
| classARentLocal | 32 USD/sqft/yr |
| classARentUsd | $32/sqft/yr |
| vacancyPct | 23.7% |
| typicalLeaseYears | 10 |
| typicalRentFreeMonths | 16 |
| talentIndex | 82 |
| corporateTaxPct | 30.6% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.